Furthermore, our team observed an extremely strong relationship between abnormally high COL10A1 expression and clinical characteristics of PRAD patients as well as patient prognosis, especially in close association with Gleason score and nodal metastasis. This evidence concerns the gene COL10A1 and prostate adenocarcinoma.